Malaignant tumors arising in inflammatory bowel disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Inflammatory bowel disease (IBD) patients have an increased risk for colorectal cancer (CRC). While not always appreciated, this is true not just for patients with ulcerative colitis (UC), but also patients with Crohn disease (CD), particularly those with Crohn colitis. While our understanding of the clinical and molecular basis for this association has improved since the first case descriptions and series were reported nearly a century ago, our means of prevention and treatment, primarily colonoscopic surveillance and prophylactic surgery, remain modest, though circumstantial evidence supports their use. CRC still accounts for a large proportion of the premature mortality in both UC and CD. This chapter will review the pathogenesis and clinical epidemiology of CRC in IBD, as well as the theoretical and literature-based strategies for CRC prevention. Additionally, the available evidence on the association between Crohn ileitis and small intestinal cancer will be presented.

Original languageEnglish (US)
Title of host publicationPediatric Inflammatory Bowel Disease, Second Edition
PublisherSpringer New York
Pages531-545
Number of pages15
ISBN (Electronic)9781461450610
ISBN (Print)9781461450603
DOIs
Publication statusPublished - Jan 1 2013
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ullman, T. A. (2013). Malaignant tumors arising in inflammatory bowel disease. In Pediatric Inflammatory Bowel Disease, Second Edition (pp. 531-545). Springer New York. https://doi.org/10.1007/978-1-4614-5061-0_49